Global Drug of Abuse Testing Market Overview
Drug of Abuse Testing Market size is projected to reach xxxx units by 2025 from an estimated xxxx unit in 2019, growing at a CAGR of xx% globally.

Global Drug of Abuse Testing Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025. The report may be the best of what is a geographic area which expands the competitive landscape and industry perspective of the market.

The report provides the comprehensive analysis of this Drug of Abuse Testing Market considering the approaches utilized by industrialists. There are some specific approaches used to safeguard their distance in market and enduring the development of business would be the variables covered in the report. For any item, there are numerous companies playing their part in the market, some new, some based and some are planning to arrive at the Drug of Abuse Testing Market..

Scope of the Drug of Abuse Testing Market
The information about Drug of Abuse Testing market obtained from sources such as sites, annual reports of many others, journals, and also those businesses and was assessed and supported by the industry experts. The details and information are represented in the accounts with charts, diagrams, pie graphs, as well as other pictorial representations. The visual image is enhanced by this and helps in understanding the truth much better.

Impact of COVID-19 on Drug of Abuse Testing Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Drug of Abuse Testing market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Market Segmentation
Global Drug of Abuse Testing Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;


Competitive Landscape and Drug of Abuse Testing Market Share Analysis
Major players in the Drug of Abuse Testing Market are identified through secondary research and their Market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and Marketing executives. The percentage splits, Market shares, growth rate and breakdowns of the product Markets are determined through using secondary sources and verified through the primary sources.

Players Covered in Drug of Abuse Testing market are :
  • Thermo Fisher Scientific
  • Siemens Medical Solutions
  • Alere
  • Firstep Bioresearch
  • Biopanda
  • BPC Biosed
  • MP Biomedicals
  • Randox Laboratories
  • Specialty Diagnostix
  • Beckman Coulter
  • Field Forensics
  • Rapid Labs
Among other players domestic and global, Drug of Abuse Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Reasons to Buy our Report:
  • The study consists of an analytical details of the global Drug of Abuse Testing market with current trends and future estimates to illustrate the impending investment pocket.
  • Global Drug of Abuse Testing market potential is determined by understanding profitability trends in order to gain stronger coverage in the market.
  • This report on Drug of Abuse Testing provides information on key impact factors, limitations, and opportunities along with detailed impact analysis.
  • The current Drug of Abuse Testing market is quantitatively analyzed from 2020 to 2025 to emphasize the financial capacity of the market.
  • Porter's five force analyzes show buyer and supplier power.


Objective to buy this Report:
  • The depth industry analysis by SWOT Analysis, Porters Five Force Analysis and Cost Structure Analysis.
  • This report covers different regional and country level markets of Drug of Abuse Testing .
  • It describes the current situation, historical background, and future forecast of the Drug of Abuse Testing .
  • Comprehensive data showing Drug of Abuse Testing capacity, production, consumption, trading statistics, and pricing.
  • Market forecasts for the next five years are also available, including market size and price by top leading vendors.
  • Raw material supply and downstream consumer information is also included in this report.
Drug of Abuse Testing Market - Current Analysis by Market Share
Segmentations by Type
  • Amphetamine (AMP) Test
  • Methamphetamine (MET) Test
  • Opiates/Morphine (OPI) Test
  • Barbiturates (BAR) Test
  • Benzodiazepines (BZO) Test
  • Other types of reagents or strips
by Application
  • Medical screening
  • Legal or forensic information
  • Employment drug testing
  • Sports/athletics testing
by Region
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)
Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  3.5.1 Drivers
  3.5.2 Restraints
  3.5.3 Opportunities
  3.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 4: Drug of Abuse Testing Market by Type
 4.1 Drug of Abuse Testing Market Overview Snapshot and Growth Engine
 4.2 Drug of Abuse Testing Market Overview
 4.3 Amphetamine (AMP) Test
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size (2016-2028F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Amphetamine (AMP) Test: Grographic Segmentation
 4.4 Methamphetamine (MET) Test
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size (2016-2028F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Methamphetamine (MET) Test: Grographic Segmentation
 4.5 Opiates/Morphine (OPI) Test
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size (2016-2028F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Opiates/Morphine (OPI) Test: Grographic Segmentation
 4.6 Barbiturates (BAR) Test
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size (2016-2028F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Barbiturates (BAR) Test: Grographic Segmentation
 4.7 Benzodiazepines (BZO) Test
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size (2016-2028F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 Benzodiazepines (BZO) Test: Grographic Segmentation
 4.8 Other types of reagents or strips
  4.8.1 Introduction and Market Overview
  4.8.2 Historic and Forecasted Market Size (2016-2028F)
  4.8.3 Key Market Trends, Growth Factors and Opportunities
  4.8.4 Other types of reagents or strips: Grographic Segmentation

Chapter 5: Drug of Abuse Testing Market by Application
 5.1 Drug of Abuse Testing Market Overview Snapshot and Growth Engine
 5.2 Drug of Abuse Testing Market Overview
 5.3 Medical screening
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Medical screening: Grographic Segmentation
 5.4 Legal or forensic information
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Legal or forensic information: Grographic Segmentation
 5.5 Employment drug testing
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Employment drug testing: Grographic Segmentation
 5.6 Sports/athletics testing
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Sports/athletics testing: Grographic Segmentation

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Positioning
  6.1.2 Drug of Abuse Testing Sales and Market Share By Players
  6.1.3 Industry BCG Matrix
  6.1.4 Ansoff Matrix
  6.1.5 Drug of Abuse Testing Industry Concentration Ratio (CR5 and HHI)
  6.1.6 Top 5 Drug of Abuse Testing Players Market Share
  6.1.7 Mergers and Acquisitions
  6.1.8 Business Strategies By Top Players
 6.2 THERMO FISHER SCIENTIFIC
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Operating Business Segments
  6.2.5 Product Portfolio
  6.2.6 Business Performance
  6.2.7 Key Strategic Moves and Recent Developments
  6.2.8 SWOT Analysis
 6.3 SIEMENS MEDICAL SOLUTIONS
 6.4 ALERE
 6.5 FIRSTEP BIORESEARCH
 6.6 BIOPANDA
 6.7 BPC BIOSED
 6.8 MP BIOMEDICALS
 6.9 RANDOX LABORATORIES
 6.10 SPECIALTY DIAGNOSTIX
 6.11 BECKMAN COULTER
 6.12 FIELD FORENSICS
 6.13 RAPID LABS

Chapter 7: Global Drug of Abuse Testing Market Analysis, Insights and Forecast, 2016-2028
 7.1 Market Overview
 7.2 Historic and Forecasted Market Size By Type
  7.2.1 Amphetamine (AMP) Test
  7.2.2 Methamphetamine (MET) Test
  7.2.3 Opiates/Morphine (OPI) Test
  7.2.4 Barbiturates (BAR) Test
  7.2.5 Benzodiazepines (BZO) Test
  7.2.6 Other types of reagents or strips
 7.3 Historic and Forecasted Market Size By Application
  7.3.1 Medical screening
  7.3.2 Legal or forensic information
  7.3.3 Employment drug testing
  7.3.4 Sports/athletics testing

Chapter 8: North America Drug of Abuse Testing Market Analysis, Insights and Forecast, 2016-2028
 8.1 Key Market Trends, Growth Factors and Opportunities
 8.2 Impact of Covid-19
 8.3 Key Players
 8.4 Key Market Trends, Growth Factors and Opportunities
 8.4 Historic and Forecasted Market Size By Type
  8.4.1 Amphetamine (AMP) Test
  8.4.2 Methamphetamine (MET) Test
  8.4.3 Opiates/Morphine (OPI) Test
  8.4.4 Barbiturates (BAR) Test
  8.4.5 Benzodiazepines (BZO) Test
  8.4.6 Other types of reagents or strips
 8.5 Historic and Forecasted Market Size By Application
  8.5.1 Medical screening
  8.5.2 Legal or forensic information
  8.5.3 Employment drug testing
  8.5.4 Sports/athletics testing
 8.6 Historic and Forecast Market Size by Country
  8.6.1 U.S.
  8.6.2 Canada
  8.6.3 Mexico

Chapter 9: Europe Drug of Abuse Testing Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Amphetamine (AMP) Test
  9.4.2 Methamphetamine (MET) Test
  9.4.3 Opiates/Morphine (OPI) Test
  9.4.4 Barbiturates (BAR) Test
  9.4.5 Benzodiazepines (BZO) Test
  9.4.6 Other types of reagents or strips
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Medical screening
  9.5.2 Legal or forensic information
  9.5.3 Employment drug testing
  9.5.4 Sports/athletics testing
 9.6 Historic and Forecast Market Size by Country
  9.6.1 Germany
  9.6.2 U.K.
  9.6.3 France
  9.6.4 Italy
  9.6.5 Russia
  9.6.6 Spain

Chapter 10: Asia-Pacific Drug of Abuse Testing Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Amphetamine (AMP) Test
  10.4.2 Methamphetamine (MET) Test
  10.4.3 Opiates/Morphine (OPI) Test
  10.4.4 Barbiturates (BAR) Test
  10.4.5 Benzodiazepines (BZO) Test
  10.4.6 Other types of reagents or strips
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Medical screening
  10.5.2 Legal or forensic information
  10.5.3 Employment drug testing
  10.5.4 Sports/athletics testing
 10.6 Historic and Forecast Market Size by Country
  10.6.1 China
  10.6.2 India
  10.6.3 Japan
  10.6.4 Southeast Asia

Chapter 11: South America Drug of Abuse Testing Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Amphetamine (AMP) Test
  11.4.2 Methamphetamine (MET) Test
  11.4.3 Opiates/Morphine (OPI) Test
  11.4.4 Barbiturates (BAR) Test
  11.4.5 Benzodiazepines (BZO) Test
  11.4.6 Other types of reagents or strips
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Medical screening
  11.5.2 Legal or forensic information
  11.5.3 Employment drug testing
  11.5.4 Sports/athletics testing
 11.6 Historic and Forecast Market Size by Country
  11.6.1 Brazil
  11.6.2 Argentina

Chapter 12: Middle East & Africa Drug of Abuse Testing Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Amphetamine (AMP) Test
  12.4.2 Methamphetamine (MET) Test
  12.4.3 Opiates/Morphine (OPI) Test
  12.4.4 Barbiturates (BAR) Test
  12.4.5 Benzodiazepines (BZO) Test
  12.4.6 Other types of reagents or strips
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Medical screening
  12.5.2 Legal or forensic information
  12.5.3 Employment drug testing
  12.5.4 Sports/athletics testing
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Saudi Arabia
  12.6.2 South Africa

Chapter 13 Investment Analysis

Chapter 14 Analyst Viewpoint and Conclusion
Drug of Abuse Testing Market - Current Analysis by Market Share
Segmentations by Type
  • Amphetamine (AMP) Test
  • Methamphetamine (MET) Test
  • Opiates/Morphine (OPI) Test
  • Barbiturates (BAR) Test
  • Benzodiazepines (BZO) Test
  • Other types of reagents or strips
by Application
  • Medical screening
  • Legal or forensic information
  • Employment drug testing
  • Sports/athletics testing
by Region
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)
LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. DRUG OF ABUSE TESTING MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. DRUG OF ABUSE TESTING MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. DRUG OF ABUSE TESTING MARKET COMPETITIVE RIVALRY
TABLE 005. DRUG OF ABUSE TESTING MARKET THREAT OF NEW ENTRANTS
TABLE 006. DRUG OF ABUSE TESTING MARKET THREAT OF SUBSTITUTES
TABLE 007. DRUG OF ABUSE TESTING MARKET BY TYPE
TABLE 008. AMPHETAMINE (AMP) TEST MARKET OVERVIEW (2016-2028)
TABLE 009. METHAMPHETAMINE (MET) TEST MARKET OVERVIEW (2016-2028)
TABLE 010. OPIATES/MORPHINE (OPI) TEST MARKET OVERVIEW (2016-2028)
TABLE 011. BARBITURATES (BAR) TEST MARKET OVERVIEW (2016-2028)
TABLE 012. BENZODIAZEPINES (BZO) TEST MARKET OVERVIEW (2016-2028)
TABLE 013. OTHER TYPES OF REAGENTS OR STRIPS MARKET OVERVIEW (2016-2028)
TABLE 014. DRUG OF ABUSE TESTING MARKET BY APPLICATION
TABLE 015. MEDICAL SCREENING MARKET OVERVIEW (2016-2028)
TABLE 016. LEGAL OR FORENSIC INFORMATION MARKET OVERVIEW (2016-2028)
TABLE 017. EMPLOYMENT DRUG TESTING MARKET OVERVIEW (2016-2028)
TABLE 018. SPORTS/ATHLETICS TESTING MARKET OVERVIEW (2016-2028)
TABLE 019. NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY TYPE (2016-2028)
TABLE 020. NORTH AMERICA DRUG OF ABUSE TESTING MARKET, BY APPLICATION (2016-2028)
TABLE 021. N DRUG OF ABUSE TESTING MARKET, BY COUNTRY (2016-2028)
TABLE 022. EUROPE DRUG OF ABUSE TESTING MARKET, BY TYPE (2016-2028)
TABLE 023. EUROPE DRUG OF ABUSE TESTING MARKET, BY APPLICATION (2016-2028)
TABLE 024. DRUG OF ABUSE TESTING MARKET, BY COUNTRY (2016-2028)
TABLE 025. ASIA PACIFIC DRUG OF ABUSE TESTING MARKET, BY TYPE (2016-2028)
TABLE 026. ASIA PACIFIC DRUG OF ABUSE TESTING MARKET, BY APPLICATION (2016-2028)
TABLE 027. DRUG OF ABUSE TESTING MARKET, BY COUNTRY (2016-2028)
TABLE 028. MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET, BY TYPE (2016-2028)
TABLE 029. MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET, BY APPLICATION (2016-2028)
TABLE 030. DRUG OF ABUSE TESTING MARKET, BY COUNTRY (2016-2028)
TABLE 031. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET, BY TYPE (2016-2028)
TABLE 032. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET, BY APPLICATION (2016-2028)
TABLE 033. DRUG OF ABUSE TESTING MARKET, BY COUNTRY (2016-2028)
TABLE 034. THERMO FISHER SCIENTIFIC: SNAPSHOT
TABLE 035. THERMO FISHER SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 036. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 037. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. SIEMENS MEDICAL SOLUTIONS: SNAPSHOT
TABLE 038. SIEMENS MEDICAL SOLUTIONS: BUSINESS PERFORMANCE
TABLE 039. SIEMENS MEDICAL SOLUTIONS: PRODUCT PORTFOLIO
TABLE 040. SIEMENS MEDICAL SOLUTIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. ALERE: SNAPSHOT
TABLE 041. ALERE: BUSINESS PERFORMANCE
TABLE 042. ALERE: PRODUCT PORTFOLIO
TABLE 043. ALERE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. FIRSTEP BIORESEARCH: SNAPSHOT
TABLE 044. FIRSTEP BIORESEARCH: BUSINESS PERFORMANCE
TABLE 045. FIRSTEP BIORESEARCH: PRODUCT PORTFOLIO
TABLE 046. FIRSTEP BIORESEARCH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. BIOPANDA: SNAPSHOT
TABLE 047. BIOPANDA: BUSINESS PERFORMANCE
TABLE 048. BIOPANDA: PRODUCT PORTFOLIO
TABLE 049. BIOPANDA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. BPC BIOSED: SNAPSHOT
TABLE 050. BPC BIOSED: BUSINESS PERFORMANCE
TABLE 051. BPC BIOSED: PRODUCT PORTFOLIO
TABLE 052. BPC BIOSED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. MP BIOMEDICALS: SNAPSHOT
TABLE 053. MP BIOMEDICALS: BUSINESS PERFORMANCE
TABLE 054. MP BIOMEDICALS: PRODUCT PORTFOLIO
TABLE 055. MP BIOMEDICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. RANDOX LABORATORIES: SNAPSHOT
TABLE 056. RANDOX LABORATORIES: BUSINESS PERFORMANCE
TABLE 057. RANDOX LABORATORIES: PRODUCT PORTFOLIO
TABLE 058. RANDOX LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. SPECIALTY DIAGNOSTIX: SNAPSHOT
TABLE 059. SPECIALTY DIAGNOSTIX: BUSINESS PERFORMANCE
TABLE 060. SPECIALTY DIAGNOSTIX: PRODUCT PORTFOLIO
TABLE 061. SPECIALTY DIAGNOSTIX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. BECKMAN COULTER: SNAPSHOT
TABLE 062. BECKMAN COULTER: BUSINESS PERFORMANCE
TABLE 063. BECKMAN COULTER: PRODUCT PORTFOLIO
TABLE 064. BECKMAN COULTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. FIELD FORENSICS: SNAPSHOT
TABLE 065. FIELD FORENSICS: BUSINESS PERFORMANCE
TABLE 066. FIELD FORENSICS: PRODUCT PORTFOLIO
TABLE 067. FIELD FORENSICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. RAPID LABS: SNAPSHOT
TABLE 068. RAPID LABS: BUSINESS PERFORMANCE
TABLE 069. RAPID LABS: PRODUCT PORTFOLIO
TABLE 070. RAPID LABS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. DRUG OF ABUSE TESTING MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. DRUG OF ABUSE TESTING MARKET OVERVIEW BY TYPE
FIGURE 012. AMPHETAMINE (AMP) TEST MARKET OVERVIEW (2016-2028)
FIGURE 013. METHAMPHETAMINE (MET) TEST MARKET OVERVIEW (2016-2028)
FIGURE 014. OPIATES/MORPHINE (OPI) TEST MARKET OVERVIEW (2016-2028)
FIGURE 015. BARBITURATES (BAR) TEST MARKET OVERVIEW (2016-2028)
FIGURE 016. BENZODIAZEPINES (BZO) TEST MARKET OVERVIEW (2016-2028)
FIGURE 017. OTHER TYPES OF REAGENTS OR STRIPS MARKET OVERVIEW (2016-2028)
FIGURE 018. DRUG OF ABUSE TESTING MARKET OVERVIEW BY APPLICATION
FIGURE 019. MEDICAL SCREENING MARKET OVERVIEW (2016-2028)
FIGURE 020. LEGAL OR FORENSIC INFORMATION MARKET OVERVIEW (2016-2028)
FIGURE 021. EMPLOYMENT DRUG TESTING MARKET OVERVIEW (2016-2028)
FIGURE 022. SPORTS/ATHLETICS TESTING MARKET OVERVIEW (2016-2028)
FIGURE 023. NORTH AMERICA DRUG OF ABUSE TESTING MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. EUROPE DRUG OF ABUSE TESTING MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. ASIA PACIFIC DRUG OF ABUSE TESTING MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET OVERVIEW BY COUNTRY (2016-2028)
Please Wait...

Frequently Asked Questions :

What would be forecast period in the market research report?
The forecast period in the market research report is 2020-2025.
Who are the key players in Drug of Abuse Testing market?
The key players mentioned are Thermo Fisher Scientific, Siemens Medical Solutions, Alere, Firstep Bioresearch, Biopanda, BPC Biosed, MP Biomedicals, Randox Laboratories, Specialty Diagnostix, Beckman Coulter, Field Forensics, Rapid Labs.
What are the segments of Drug of Abuse Testing market?
The Drug of Abuse Testing market is segmented into application type, product type and region. By Application type, the market is categorized into Medical screening, Legal or forensic information, Employment drug testing, Sports/athletics testing. By product type, it is classified into Amphetamine (AMP) Test, Methamphetamine (MET) Test, Opiates/Morphine (OPI) Test, Barbiturates (BAR) Test, Benzodiazepines (BZO) Test, Other types of reagents or strips and others. By region, it is analysed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.), Asia-Pacific (China; India; Japan; Southeast Asia etc.), South America (Brazil; Argentina etc.), Middle East & Africa (Saudi Arabia; South Africa etc.).
What is the Drug of Abuse Testing market?
Drug of Abuse Testing Market size is projected to reach xxxx units by 2025 from an estimated xxxx unit in 2019, growing at a CAGR of xx% globally.
How big is the Drug of Abuse Testing market?
The global Drug of Abuse Testing market size was estimated at USD XX billion in 2019 and is expected to reach USD XX million in 2025.